|
1
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar :
|
|
2
|
Lao VV and Grady WM: Epigenetics and
colorectal cancer. Nat Rev Gastro Hepat. 8:686–700. 2011.
View Article : Google Scholar
|
|
3
|
Martenson JA, Haddock MG and Gunderson LL:
Cancers of the Colon, Rectum, and Anus. Springer Berlin Heidelberg.
34:545–559. 2006.
|
|
4
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Migliore L, Migheli F, Spisni R and
Coppedè F: Genetics, cytogenetics, and epigenetics of colorectal
cancer. J Biomed Biotechnol. 2011:7923622011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pox CP: Controversies in colorectal cancer
screening. Digestion. 89:274–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lieu C and Kopetz S: The SRC family of
protein tyrosine kinases: A new and promising target for colorectal
cancer therapy. Clin Colorectal Cancer. 9:89–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin JS, Piper MA, Perdue LA, Rutter CM,
Webber EM, O'Connor E, Smith N and Whitlock EP: Screening for
colorectal cancer: Updated evidence report and systematic review
for the US preventive services task force. JAMA. 315:2576–2594.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang ZP and Südhof TC: Cell biology of
Ca2+-triggered exocytosis. Curr Opin Cell Biol.
22:496–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fernández-Chacón R, Königstorfer A, Gerber
SH, García J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C
and Südhof TC: Synaptotagmin I functions as a calcium regulator of
release probability. Nature. 410:41–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brose N, Petrenko AG, Südhof TC and Jahn
R: Synaptotagmin: A calcium sensor on the synaptic vesicle surface.
Science. 256:1021–1025. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sutton RB, Davletov BA, Berghuis AM,
Sudhof TC and Sprang SR: Structure of the first C2 domain of
synaptotagmin I: A novel Ca2+/phospholipid-binding fold.
Cell. 80:929–938. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perin MS, Fried VA, Mignery GA, Jahn R and
Südhof TC: Phospholipid binding by a synaptic vesicle protein
homologous to the regulatory region of protein kinase C. Nature.
345:260–263. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fukuda M and Mikoshiba K: Characterization
of KIAA1427 protein as an atypical synaptotagmin (Syt XIII).
Biochem J. 354:249–257. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Von CP and Südhof TC: Synaptotagmin 13:
Structure and expression of a novel synaptotagmin. Eur J Cell Biol.
80:41–47. 2001. View Article : Google Scholar
|
|
16
|
Rickman C, Craxton M, Osborne S and
Davletov B: Comparative analysis of tandem C2 domains from the
mammalian synaptotagmin family. Biochem J. 378:681–686. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grønborg M, Kristiansen TZ, Iwahori A,
Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins
MG, et al: Biomarker discovery from pancreatic cancer secretome
using a differential proteomic approach. Mol Cell Proteomics.
5:157–171. 2006. View Article : Google Scholar
|
|
18
|
Jahn JE and Coleman WB: Re-expression of
tumorigenicity after attenuation of human synaptotagmin 13 in a
suppressed micro-cell hybrid cell line. Int J Oncol. 32:441–449.
2008.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
László L: Predictive and prognostic
factors in the complex treatment of patients with colorectal
cancer. Magy Onkol. 54:383–394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kulendran M, Stebbing JF, Marks CG and
Rockall TA: Predictive and prognostic factors in colorectal cancer:
A personalized approach. Cancers (Basel). 3:1622–1638. 2011.
View Article : Google Scholar
|
|
22
|
Chen TH, Chang SW, Huang CC, Wang KL, Yeh
KT, Liu CN, Lee H, Lin CC and Cheng YW: The prognostic significance
of APC gene mutation and miR-21 expression in advanced-stage
colorectal cancer. Colorectal Dis. 15:1367–1374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Falchook GS and Kurzrock R: VEGF and
dual-EGFR inhibition in colorectal cancer. Cell Cycle.
14:1129–1130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao J, Lv D, Zhou J, Bei Y, Chen T, Hu M,
Zhou Q, Fu S and Huang Q: Therapeutic inhibition of miR-4260
suppresses colorectal cancer via targeting MCC and SMAD4.
Theranostics. 7:1901–1913. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koga Y, Yasunaga M, Takahashi A, Kuroda J,
Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H and Matsumura Y:
MicroRNA expression profiling of exfoliated colonocytes isolated
from feces for colorectal cancer screening. Cancer Prev Res
(Phila). 3:1435–1442. 2010. View Article : Google Scholar
|
|
26
|
Huang Z, Huang DS, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar
|
|
27
|
Li D, Yan D, Tang H, Zhou C, Fan J, Li S,
Wang X, Xia J, Huang F, Qiu G and Peng Z: IMP3 is a novel
prognostic marker that correlates with colon cancer progression and
pathogenesis. Ann Surg Oncol. 16:3499–3506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin L, Zhang J, Wang Y, Ju W, Ma Y, Li L
and Chen L: Insulin-like growth factor-II mRNA-binding protein 3
predicts a poor prognosis for colorectal adenocarcinoma. Oncol
Lett. 6:740–744. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnson CP: Emerging functional
differences between the synaptotagmin and ferlin calcium sensor
families. Biochemistry. 56:6413–6417. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizuta M, Inagaki N, Nemoto Y, Matsukura
S, Takahashi M and Seino S: Synaptotagmin III is a novel isoform of
rat synaptotagmin expressed in endocrine and neuronal cells. J Biol
Chem. 269:11675–11678. 1994.PubMed/NCBI
|
|
31
|
Grise F, Taib N, Monterrat C, Lagrée V and
Lang J: Distinct roles of the C(2)A and the C2B domain of the
vesicular Ca2+ sensor synaptotagmin 9 in endocrine
beta-cells. Biochem J. 403:483–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andersson SA, Olsson AH, Esguerra JL,
Heimann E, Ladenvall C, Edlund A, Salehi A, Taneera J, Degerman E,
Groop L, et al: Reduced insulin secretion correlates with decreased
expression of exocytotic genes in pancreatic islets from patients
with type 2 diabetes. Mol Cell Endocrinol. 364:36–45. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sreenath AS, Kumar KR, Reddy GV, Sreedevi
B, Praveen D, Monika S, Sudha S, Reddy MG and Reddanna P: Evidence
for the association of synaptotagmin with glutathione
S-transferases: Implications for a novel function in human breast
cancer. Clin Biochem. 38:436–443. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thierry-Mieg D and Thierry-Mieg J:
AceView: A comprehensive cDNA-supported gene and transcripts
annotation. Genome Biol. 7(Suppl 1): S122006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han S, Hong S, Lee D, Lee MH, Choi JS, Koh
MJ, Sun W, Kim H and Lee HW: Altered expression of synaptotagmin 13
mRNA in adult mouse brain after contextual fear conditioning.
Biochem Biophys Res Commun. 425:880–885. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Keck KJ, Breheny P, Braun TA, Darbro B, Li
G, Dillon JS, Bellizzi AM, O'Dorisio TM and Howe JR: Changes in
gene expression in small bowel neuroendocrine tumors associated
with progression to metastases. Surgery. 163:232–239. 2018.
View Article : Google Scholar
|
|
37
|
Jahn JE, Best DH and Coleman WB: Exogenous
expression of synaptotagmin XIII suppresses the neoplastic
phenotype of a rat liver tumor cell line through molecular pathways
related to mesenchymal to epithelial transition. Exp Mol Pathol.
89:209–216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu H, Wu TC, Chen WQ, Zhou LJ, Wu Y, Zeng
L and Pei HP: Screening for differentially expressed genes between
left- and right-sided colon carcinoma by microarray analysis. Oncol
Lett. 6:353–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
